These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
790 related articles for article (PubMed ID: 28611128)
1. Decreased KCNE2 Expression Participates in the Development of Cardiac Hypertrophy by Regulation of Calcineurin-NFAT (Nuclear Factor of Activated T Cells) and Mitogen-Activated Protein Kinase Pathways. Liu W; Deng J; Ding W; Wang G; Shen Y; Zheng J; Zhang X; Luo Y; Lv C; Wang Y; Chen L; Yan D; Boudreau RL; Song LS; Liu J Circ Heart Fail; 2017 Jun; 10(6):. PubMed ID: 28611128 [TBL] [Abstract][Full Text] [Related]
2. Hypoxia-Induced Mitogenic Factor Promotes Cardiac Hypertrophy via Calcium-Dependent and Hypoxia-Inducible Factor-1α Mechanisms. Kumar S; Wang G; Liu W; Ding W; Dong M; Zheng N; Ye H; Liu J Hypertension; 2018 Aug; 72(2):331-342. PubMed ID: 29891648 [TBL] [Abstract][Full Text] [Related]
3. The Ca(v)3.2 T-type Ca(2+) channel is required for pressure overload-induced cardiac hypertrophy in mice. Chiang CS; Huang CH; Chieng H; Chang YT; Chang D; Chen JJ; Chen YC; Chen YH; Shin HS; Campbell KP; Chen CC Circ Res; 2009 Feb; 104(4):522-30. PubMed ID: 19122177 [TBL] [Abstract][Full Text] [Related]
4. Polydatin attenuates cardiac hypertrophy through modulation of cardiac Ca2+ handling and calcineurin-NFAT signaling pathway. Ding W; Dong M; Deng J; Yan D; Liu Y; Xu T; Liu J Am J Physiol Heart Circ Physiol; 2014 Sep; 307(5):H792-802. PubMed ID: 25015961 [TBL] [Abstract][Full Text] [Related]
5. Stachydrine hydrochloride suppresses phenylephrine-induced pathological cardiac hypertrophy by inhibiting the calcineurin/nuclear factor of activated T-cell signalling pathway. Zheng J; Tian J; Wang S; Hu P; Wu Q; Shan X; Zhao P; Zhang C; Guo W; Xu M; Chen H; Lu R Eur J Pharmacol; 2020 Sep; 883():173386. PubMed ID: 32712088 [TBL] [Abstract][Full Text] [Related]
6. Cooperative Binding of ETS2 and NFAT Links Erk1/2 and Calcineurin Signaling in the Pathogenesis of Cardiac Hypertrophy. Luo Y; Jiang N; May HI; Luo X; Ferdous A; Schiattarella GG; Chen G; Li Q; Li C; Rothermel BA; Jiang D; Lavandero S; Gillette TG; Hill JA Circulation; 2021 Jul; 144(1):34-51. PubMed ID: 33821668 [TBL] [Abstract][Full Text] [Related]
7. Calcineurin-nuclear factor of activated T cells pathway-dependent cardiac remodeling in mice deficient in guanylyl cyclase A, a receptor for atrial and brain natriuretic peptides. Tokudome T; Horio T; Kishimoto I; Soeki T; Mori K; Kawano Y; Kohno M; Garbers DL; Nakao K; Kangawa K Circulation; 2005 Jun; 111(23):3095-104. PubMed ID: 15939815 [TBL] [Abstract][Full Text] [Related]
8. LIM and cysteine-rich domains 1 regulates cardiac hypertrophy by targeting calcineurin/nuclear factor of activated T cells signaling. Bian ZY; Huang H; Jiang H; Shen DF; Yan L; Zhu LH; Wang L; Cao F; Liu C; Tang QZ; Li H Hypertension; 2010 Feb; 55(2):257-63. PubMed ID: 20026769 [TBL] [Abstract][Full Text] [Related]
9. Aspirin Attenuates Angiotensin II-induced Cardiomyocyte Hypertrophy by Inhibiting the Ca(2+)/Calcineurin-NFAT Signaling Pathway. Yin Z; Wang X; Zhang L; Zhou H; Wei L; Dong X Cardiovasc Ther; 2016 Feb; 34(1):21-9. PubMed ID: 26506219 [TBL] [Abstract][Full Text] [Related]
10. Leptin-induced cardiomyocyte hypertrophy reveals both calcium-dependent and calcium-independent/RhoA-dependent calcineurin activation and NFAT nuclear translocation. Rajapurohitam V; Izaddoustdar F; Martinez-Abundis E; Karmazyn M Cell Signal; 2012 Dec; 24(12):2283-90. PubMed ID: 22917533 [TBL] [Abstract][Full Text] [Related]
11. TRPC4α and TRPC4β Similarly Affect Neonatal Cardiomyocyte Survival during Chronic GPCR Stimulation. Kirschmer N; Bandleon S; von Ehrlich-Treuenstätt V; Hartmann S; Schaaf A; Lamprecht AK; Miranda-Laferte E; Langsenlehner T; Ritter O; Eder P PLoS One; 2016; 11(12):e0168446. PubMed ID: 27992507 [TBL] [Abstract][Full Text] [Related]
12. Calcineurin-NFAT signaling regulates the cardiac hypertrophic response in coordination with the MAPKs. Molkentin JD Cardiovasc Res; 2004 Aug; 63(3):467-75. PubMed ID: 15276472 [TBL] [Abstract][Full Text] [Related]
13. TAK1 Regulates Myocardial Response to Pathological Stress via NFAT, NFκB, and Bnip3 Pathways. Li L; Chen Y; Li J; Yin H; Guo X; Doan J; Molkentin JD; Liu Q Sci Rep; 2015 Nov; 5():16626. PubMed ID: 26564789 [TBL] [Abstract][Full Text] [Related]
14. CaMKII negatively regulates calcineurin-NFAT signaling in cardiac myocytes. MacDonnell SM; Weisser-Thomas J; Kubo H; Hanscome M; Liu Q; Jaleel N; Berretta R; Chen X; Brown JH; Sabri AK; Molkentin JD; Houser SR Circ Res; 2009 Aug; 105(4):316-25. PubMed ID: 19608982 [TBL] [Abstract][Full Text] [Related]
15. PICOT attenuates cardiac hypertrophy by disrupting calcineurin-NFAT signaling. Jeong D; Kim JM; Cha H; Oh JG; Park J; Yun SH; Ju ES; Jeon ES; Hajjar RJ; Park WJ Circ Res; 2008 Mar; 102(6):711-9. PubMed ID: 18258855 [TBL] [Abstract][Full Text] [Related]
16. Calcineurin independent development of myocardial hypertrophy in transgenic rats overexpressing the mouse renin gene, TGR(mREN2)27. Diedrichs H; Mei C; Frank KF; Boelck B; Schwinger RH J Mol Med (Berl); 2004 Oct; 82(10):688-95. PubMed ID: 15322704 [TBL] [Abstract][Full Text] [Related]
17. Prevention of hypertrophy by overexpression of Kv4.2 in cultured neonatal cardiomyocytes. Zobel C; Kassiri Z; Nguyen TT; Meng Y; Backx PH Circulation; 2002 Oct; 106(18):2385-91. PubMed ID: 12403671 [TBL] [Abstract][Full Text] [Related]
18. Enhanced expression of DYRK1A in cardiomyocytes inhibits acute NFAT activation but does not prevent hypertrophy in vivo. Grebe C; Klingebiel TM; Grau SP; Toischer K; Didié M; Jacobshagen C; Dullin C; Hasenfuss G; Seidler T Cardiovasc Res; 2011 Jun; 90(3):521-8. PubMed ID: 21273244 [TBL] [Abstract][Full Text] [Related]
19. COX-2 is involved in ET-1-induced hypertrophy of neonatal rat cardiomyocytes: role of NFATc3. Li H; Gao S; Ye J; Feng X; Cai Y; Liu Z; Lu J; Li Q; Huang X; Chen S; Liu P Mol Cell Endocrinol; 2014 Feb; 382(2):998-1006. PubMed ID: 24291639 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of calcineurin-NFAT hypertrophy signaling by cGMP-dependent protein kinase type I in cardiac myocytes. Fiedler B; Lohmann SM; Smolenski A; Linnemuller S; Pieske B; Schroder F; Molkentin JD; Drexler H; Wollert KC Proc Natl Acad Sci U S A; 2002 Aug; 99(17):11363-8. PubMed ID: 12177418 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]